Harrow Health, Inc. (HROW) Social Stream
HARROW INC (HROW) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HROW.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-11 | 3 | $16.5 | $15 | $15.833 | $10 | 58.33% |
| 2022-05-06 | 3 | $17 | $15 | $16.166 | $10 | 61.66% |
| 2022-05-20 | 3 | $20 | $15 | $17.166 | $10 | 71.66% |
| 2022-08-11 | 2 | $16.5 | $16 | $16.25 | $10 | 62.5% |
| 2022-09-08 | 3 | $17 | $16 | $16.5 | $10 | 65% |
| 2022-11-15 | 2 | $17 | $16 | $16.5 | $10 | 65% |
| 2023-01-05 | 2 | $22 | $16 | $18.166 | $10 | 81.66% |
| 2023-03-26 | 3 | $27.2 | $16 | $22.4 | $10 | 124% |
| 2023-04-17 | 3 | $37 | $16 | $26.05 | $10 | 160.5% |
| 2023-05-04 | 3 | $42 | $16 | $30.55 | $10 | 205.5% |
| 2023-05-12 | 3 | $42 | $32.4 | $37.133 | $10 | 271.33% |
| 2023-07-20 | 3 | $45 | $32.4 | $38.133 | $10 | 281.33% |
| 2023-08-10 | 3 | $45 | $33.7 | $38.566 | $10 | 285.66% |
| 2023-10-30 | 3 | $45 | $34.4 | $38.8 | $10 | 288% |
| 2023-11-14 | 3 | $37 | $30 | $33.8 | $10 | 238% |
The Trend in the Analyst Price Target
HROW's average price target has moved up $18.67 over the prior 27 months.
HROW reports an average of 99.41% for its upside potential over the past 33 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-04 | 3 | 42.0 | 16.0 | 30.550 | 25.73 | 18.73% |
| 2023-07-25 | 3 | 45.0 | 33.7 | 38.566 | 21.23 | 81.66% |
| 2023-08-10 | 3 | 45.0 | 33.7 | 38.566 | 16.74 | 130.38% |
| 2023-08-11 | 3 | 45.0 | 34.4 | 38.800 | 16.93 | 129.18% |
| 2023-11-14 | 3 | 34.4 | 20.0 | 28.133 | 8.21 | 242.67% |
HROW Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 28 months, HROW's average broker recommendation rating improved by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- HROW has a higher number of analysts covering the stock than 114.64% of all US stocks.
- HROW has a higher upside potential (average analyst target price relative to current price) than 1477.11% of all US stocks.
- HROW has a lower variance in analysts' estimates than -274.19% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, HARROW INC's average analyst price target is higher than 1144.74% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HARROW INC are VNDA, OMER, and MACK.
View All Top Stocks by Price Target
What is the outlook for HROW? Use POWR Ratings for clearer insight into price direction.